Literature DB >> 28886622

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Marco Valgimigli, Héctor Bueno, Robert A Byrne, Jean-Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe Kolh, Laura Mauri, Gilles Montalescot, Franz-Josef Neumann, Mate Petricevic, Marco Roffi, Philippe Gabriel Steg, Stephan Windecker, Jose Luis Zamorano, Glenn N Levine.   

Abstract

Entities:  

Keywords:  Acute coronary syndromes; Aspirin; Bleeding; Clopidogrel; Coronary artery bypass grafting; Coronary artery disease; DAPT score; Drug-eluting stents; Dual antiplatelet therapy; Guidelines; Myocardial infarction; Non-cardiac surgery; Oral anticoagulant; PRECISE-DAPT score; Percutaneous coronary intervention; Prasugrel; Recommendation; Revascularization; Risk stratification; Stable angina; Stable coronary artery disease; Stent thrombosis; Stents; Ticagrelor; Triple therapy

Mesh：

Substances：

Year:  2018        PMID： 28886622     DOI： 10.1093/eurheartj/ehx419

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  502 in total

1.  Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.

Authors:  Joo-Yong Hahn; Young Bin Song; Ju-Hyeon Oh; Woo Jung Chun; Yong Hawn Park; Woo Jin Jang; Eul-Soon Im; Jin-Ok Jeong; Byung Ryul Cho; Seok Kyu Oh; Kyeong Ho Yun; Deok-Kyu Cho; Jong-Young Lee; Young-Youp Koh; Jang-Whan Bae; Jae Woong Choi; Wang Soo Lee; Hyuck Jun Yoon; Seung Uk Lee; Jang Hyun Cho; Woong Gil Choi; Seung-Woon Rha; Joo Myung Lee; Taek Kyu Park; Jeong Hoon Yang; Jin-Ho Choi; Seung-Hyuck Choi; Sang Hoon Lee; Hyeon-Cheol Gwon
Journal:  JAMA       Date:  2019-06-25       Impact factor: 56.272

2.  A direct oral factor Xa inhibitor edoxaban ameliorates neointimal hyperplasia following vascular injury and thrombosis in apolipoprotein E-deficient mice.

Authors:  Yoshiyuki Morishima; Yuko Honda
Journal:  J Thromb Thrombolysis       Date:  2018-07       Impact factor: 2.300

Review 3.  Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies.

Authors:  Alexandru Burlacu; Simonetta Genovesi; Carlo Basile; Alberto Ortiz; Sandip Mitra; Dimitrios Kirmizis; Mehmet Kanbay; Andrew Davenport; Frank van der Sande; Adrian Covic
Journal:  J Nephrol       Date:  2020-05-29       Impact factor: 3.902

Review 4.  Coronary Stent Thrombosis- Predictors and Prevention.

Authors:  Helen Ullrich; Thomas Münzel; Tommaso Gori
Journal:  Dtsch Arztebl Int       Date:  2020-05-01       Impact factor: 5.594

5.  Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018.

Authors:  Nayyra Fatani; Christopher Fanikos; Clara Ting; Leo F Buckley; John Fanikos
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

Review 6.  Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges.

Authors:  Debashish Das; Alex Asher; Arjun K Ghosh
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

7.  Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C19*2 genotype?

Authors:  Saoussen Chouchene; Rym Dabboubi; Haythem Raddaoui; Hela Abroug; Khaldoun Ben Hamda; Sondess Hadj Fredj; Fatma Abderrazak; Mayssa Gaaloul; Marwa Rezek; Fadoua Neffeti; Ilhem Hellara; Mouna Sassi; Linda Khefacha; Asma Sriha; Semir Nouira; Mohamed Fadhel Najjar; Faouzi Maatouk; Taieb Messaoud; Mohsen Hassine
Journal:  Eur J Clin Pharmacol       Date:  2018-08-03       Impact factor: 2.953

Review 8.  Arterial events in cancer patients-the case of acute coronary thrombosis.

Authors:  Ohad Oren; Joerg Herrmann
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 9.  [ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].

Authors:  F-J Neumann; W Hochholzer; M Siepe
Journal:  Herz       Date:  2018-12       Impact factor: 1.443

10.  Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial.

Authors:  Giuseppe Gargiulo; Giovanni Esposito; Plinio Cirillo; Michael Nagler; Pietro Minuz; Gianluca Campo; Felice Gragnano; Negar Manavifar; Raffaele Piccolo; Marisa Avvedimento; Matteo Tebaldi; Andreas Wahl; Lukas Hunziker; Michael Billinger; Dik Heg; Stephan Windecker; Marco Valgimigli
Journal:  J Cardiovasc Transl Res       Date:  2020-02-24       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.